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Cocaine Enhances HIV-1eAssociated CD4D
T-Cell Apoptosis
Cocaine has been suggested to accelerate HIV disease pro-
gression. Pandhare et al (Am J Pathol 2014, 184:927e936)
tested whether cocaine augments HIV-1eassociated CD4þ T
cell decline, which is a predictor of HIV disease progression.
Treatment of resting CD4þ T cells with up to 100 mmol/L
cocaine did not induce apoptosis, but 200 to 1000 mmol/L
cocaine induced apoptosis in a dose-dependent manner. Treat-
ment of healthydonorCD4þTcellswithbothHIV-1virions and
cocaine signiﬁcantly increased apoptosis compared to that
inducedby cocaine or virions alone.Biochemical data suggested
that cocaine induces CD4þ T-cell apoptosis by increasing
intracellular reactive oxygen species levels and inducing mito-
chondrial depolarization. Thus, the synergy between cocaine
and HIV-1 on CD4þ T-cell apoptosis may in part explain the
accelerated disease observed in HIV-1einfected drug abusers.
a-Synuclein and Parkinson Disease Progression
a-Synuclein expression is altered in the cerebrospinal ﬂuid of
Parkinson disease patients. However, it is not known whether
it predictsmotor or cognitive deterioration. Stewart et al (AmJ
Pathol 2014, 184:966e975) examined the relationships be-
tween a-synuclein levels in cerebrospinal ﬂuid and measures
of disease severity and progression in greater than 300 un-
medicated Parkinson disease patients who participated in the
deprenyl and tocopherol antioxidative therapy of Parkin-
sonism (DATATOP) study. Despite decreasing a-synuclein
levels, no correlationswere observed betweena-synuclein and
motor symptoms. Longitudinally, though, lower a-synuclein
levels predicted better preservation of cognitive function by
several measures. Thus, although not clinically useful for
motor progression, a-synuclein levels might predict cognitive
decline, indicating the need for future longitudinal studies.
Hyperoxia Alters Lung Development
Exposure of newborn mice to hyperoxia arrests lung develop-
ment, with resultant pathology similar to bronchopulmonary
dysplasia in infants born prematurely. Rieger-Fackeldey et al
(Am J Pathol 2014,184:1010e1016) hypothesized that
aberrations in lung development in newborn FVB mice
caused by 14 days of sublethal hyperoxia could be reversed
by gradual weaning to room air. Newborn mice exposed toCopyright ª 2014 American Society for Investigative Pathology.
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http://dx.doi.org/10.1016/j.ajpath.2014.01.01585% oxygen (hyperoxia) for 14 days were weaned either
directly or gradually by 10% per day over the next 6 days.
Lungs of P28 mice weaned abruptly from hyperoxia had
fewer and larger alveoli than those weaned gradually; lungs
from both hyperoxia-exposed groups differed from lungs
obtained from air-breathing controls. These results suggest
that weaning should be considered in experimental models of
newborn exposure to hyperoxia.
Diabetes Increases Severity of Tuberculosis
An animal model that closely mimics the pathogenesis of type
2 diabetes and tuberculosis (TB) comorbidity in humans is
currently lacking. Using guinea pigs, Podell et al (Am J Pathol
2014, 184:1104e1118) modeled the emerging comorbidity of
Mycobacterium tuberculosis infection with impaired glucose
tolerance. M. tuberculosis infection of diabetic guinea pigs
resulted in an overall increase in disease severity, including
higher bacterial burden, compared to glucose-intolerant and
nondiabetic controls. Compared to nondiabetic animals, dia-
betic guinea pigs with TB had an exacerbated proinﬂammatory
response with more severe granulocytic inﬂammation. Differ-
ences in response to M. tuberculosis infection in guinea pigs
with impaired glucose tolerance were not seen until the chronic
stages of infection. This model may aid in understanding the
complex comorbidity of TB and diabetes and in testing new
treatment strategies when the two diseases occur together.
Is There a Shared Origin for Luminal-Like and
HER2-Enriched Breast Cancer?
Understanding the phenotypic evolution of breast cancer
through distinct subtypes heavily relies on deﬁning a lineage
blueprint of the normal human breast. Using an antibody library,
Balk-Møller et al (Am J Pathol 2014, 184:1198e1208)
screened for heterogeneity in thenormal humanbreast andbreast
with cancer with respect to covariation with ERa expression.
Screening revealed a high correlation between expression of
CEACAM6 and endocrine receptors in normal human breast
tissues and in primary cell cultures, aswell as a strong correlation
between CEACAM6 expression and luminal subtype. More
importantly, luminal differentiation by CEACAM6 expression
also appeared to be a hallmark ofHER2-enriched breast cancers.
Thus, ERa-positive cells from different classes of breast cancer
share properties with physiologically normal cells, suggesting a
possible common origin for luminal-like and HER2-enriched
breast cancer subtypes.
